Salesh Balak - Apr 20, 2023 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC (UBI)

Role
Chief Financial Officer
Signature
/s/ Salesh Balak
Stock symbol
UBI
Transactions as of
Apr 20, 2023
Transactions value $
$0
Form type
4
Date filed
4/27/2023, 06:54 PM
Previous filing
Jan 3, 2023
Next filing
Feb 28, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding UBI Common Stock 389K Apr 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBI Stock Option (Right to Buy) Other $0 -721K -100% $0.00* 0 Apr 20, 2023 Common Stock 721K $0.50 Direct F1, F3
holding UBI Performance Rights 500K Apr 20, 2023 Common Stock 500K Direct F5
holding UBI Performance Rights 250K Apr 20, 2023 Common Stock 250K Direct F6
holding UBI Stock Option (Right to Buy) 500K Apr 20, 2023 Common Stock 500K $0.30 Direct F1, F2
holding UBI Stock Option (Right to Buy) 216K Apr 20, 2023 Common Stock 216K $0.50 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is stated in Australian dollars.
F2 The options are fully vested and became exercisable on 03/01/2021.
F3 These options expired on April 20, 2023.
F4 216,300 stock options vested and became exercisable on 12/31/2017.
F5 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F6 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.